Tropical cyclone motion: environmental interacton plus a beta efect

Includes bibliographical references.ONR N00014-C-0793

Topological conjugation classes of tightly transitive subgroups of Homeo+(S1)\text{Homeo}_{+}(\mathbb{S}^1)

Let $\text{Homeo}_{+}(\mathbb{S}^1)$ denote the group of orientation preserving homeomorphisms of the circle $\mathbb{S}^1$. A subgroup $G$ of $\text{Homeo}_{+}(\mathbb{S}^1)$ is tightly transitive if it is topologically transitive and no subgroup $H$ of $G$ with $[G: H]=\infty$ has this property; is almost minimal if it has at most countably many nontransitive points. In the paper, we determine all the topological conjugation classes of tightly transitive and almost minimal subgroups of $\text{Homeo}_{+}(\mathbb{S}^1)$ which are isomorphic to $\mathbb{Z}^n$ for any integer $n\geq 2$.Comment: 17 pages, 4 figure

Estimating carbon dioxide residence time scales through noble gas and stable isotope diffusion profiles

The study of natural carbon dioxide reservoirs provides fundamental insight into processes involved in carbon capture and storage. However, the calculations of process rates such as dissolution of CO2 into formation water remain uncertain due to indirectly determined ages of the CO2 influx. The proposed ages for the Bravo Dome gas field in New Mexico, USA, vary from 56 ka to 1.5 Ma. Here we demonstrate that residence times can be estimated from simple modeling of noble gas and stable isotope diffusion profiles from the gas-water contact through the gas column. The Bravo Dome gas field shows a gradient in noble gas concentrations and isotopic ratios from east to west across the 70-km-wide field. A mantle-like end member with a 3He/4He (R/RA) ratio of up to 4.7 is found in the west in contrast to a groundwater end member with high concentrations of air- and crustal-derived noble gases in the east. The air- and crustal-derived noble gases decrease gradually toward the west. Stable isotope compositions (C and O) also vary across the field. Diffusion modeling of He, Ne, Ar, Kr, Xe, and δ13C data yield residence times for the CO2 between 14.1 ± 0.2 ka and 16.9 +1.1/–0.5 ka. This is far less than the previous estimates of 1.2–1.5 Ma based on apatite (U-Th)/He thermochronology, leading to a dissolution rate of 29,900 +11,800/–10,700 t/a to 35,900 ± 12,300 t/a, implying that 28% of the total emplaced CO2 dissolved. This new method can be applied to a wide variety of gas fields with variation in the concentration of groundwater-derived noble gases and allow a better assessment of the time scale of other diffusive fluid-fluid interactions

Optimized simultaneous ASL and BOLD functional imaging of the whole brain

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/106990/1/jmri24273.pd

Using noble gases to trace groundwater evolution and assess helium accumulation in Weihe Basin, central China

The severe shortage of helium resources is an impending global problem. However, the helium accumulation processes and conditions favorable for helium enrichment in reservoirs remain poorly understood, which makes helium exploration challenging. Noble gases are good tracers of subsurface fluids provenance, migration and storage, as well as indicators of the nature and quantity of associated phases. In this study the variation of major gases and noble gases data in Weihe Basin provide us with an excellent opportunity to understand the groundwater evolution and helium accumulation processes. Twelve gas samples collected from wellheads of geothermal wells can be classified into three groups, in which Group A has high concentrations of N2 (58.57% - 91.66%) and He (0.32% - 2.94%); Group B has high contents of CH4 (52.94% and 69.50%) and low concentrations of He (0.057% and 0.062%); Group C has a high content of CH4 (71.70%) and He (2.11%). Helium isotopic ratios are predominantly radiogenic in origin and therefore crustally derived. Measured elemental ratios of noble gases are compared with multiple fractionation models for Group A and B samples, implying that open system heavy oil-water fractionation with excess heavy noble gases has occurred in the basin with Voil/Vwater ratios of 0.06-0.18. The amount of helium in Group A and B samples requires the release of all 4He produced in the crust since 0.30Ma-1.98Ma into the groundwater. The Group C sample requires an additional He flux from adjacent granitic bodies. The accumulation of helium and hydrocarbon in the Weihe Basin can be explained by a 4-stage process. Accumulation of commercially viable helium requires high He flux from source rocks, the existence of a free gas phase of major gas components (CH4 in most cases, N2 or CO2) and minimal major gas addition after formation of the free gas phase

Phase II multicentre, double-blind, randomised trial of ustekinumab in adolescents with new-onset type 1 diabetes (USTEK1D): trial protocol

Introduction Most individuals newly diagnosed with type 1 diabetes (T1D) have 10%–20% of beta-cell function remaining at the time of diagnosis. Preservation of residual beta-cell function at diagnosis may improve glycaemic control and reduce longer-term complications.Immunotherapy has the potential to preserve endogenous beta-cell function and thereby improve metabolic control even in poorly compliant individuals. We propose to test ustekinumab (STELARA), a targeted and well-tolerated therapy that may halt T-cell and cytokine-mediated destruction of beta-cells in the pancreas at the time of diagnosis.Methods and analysis This is a double-blind phase II study to assess the safety and efficacy of ustekinumab in 72 children and adolescents aged 12–18 with new-onset T1D.Participants should have evidence of residual functioning beta-cells (serum C-peptide level >0.2nmol/L in the mixed-meal tolerance test (MMTT) and be positive for at least one islet autoantibody (GAD, IA-2, ZnT8) to be eligible.Participants will be given ustekinumab/placebo subcutaneously at weeks 0, 4 and 12, 20, 28, 36 and 44 in a dose depending on the body weight and will be followed for 12 months after dose 1.MMTTs will be used to measure the efficacy of ustekinumab for preserving C-peptide area under the curve at week 52 compared with placebo. Secondary objectives include further investigations into the efficacy and safety of ustekinumab, patient and parent questionnaires, alternative methods for measuring insulin production and exploratory mechanistic work